• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种规划策略可能降低心脏病和放射性肺炎的风险:避免特定的心脏亚结构。

A planning strategy may reduce the risk of heart diseases and radiation pneumonia: Avoiding the specific heart substructures.

机构信息

Institute of Modern Physics, Fudan University, Shanghai, China.

Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Fudan University, Shanghai, China.

出版信息

J Appl Clin Med Phys. 2023 Dec;24(12):e14119. doi: 10.1002/acm2.14119. Epub 2023 Aug 11.

DOI:10.1002/acm2.14119
PMID:37568269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10691619/
Abstract

BACKGROUND

Dose to heart substructures is a better predictor for major adverse cardiac events (MACE) than mean heart dose (MHD). We propose an avoidance planning strategy for important cardiac substructures.

MATERIAL AND METHODS

Two plans, clinical and cardiac substructure-avoidance plan, were generated for twenty patients. Five dose-sensitive substructures, including left ventricle, pulmonary artery, left anterior descending branch, left circumflex branch and the coronary artery were chosen. The avoidance plan aims to meet the target criteria and organ-at-risk (OARs) constraints while minimizing the dose parameters of the above five substructures. The dosimetric assessments included the mean dose and the maximum dose of cardiac substructures and several volume parameters. In addition, we also evaluated the relative risk of coronary artery disease (CAD), chronic heart failure (CHF), and radiation pneumonia (RP).

RESULTS

Pearson correlation coefficient and R value of linear regression fitting demonstrated that MHD had poor prediction ability for the mean dose of the cardiac substructures. Compared to clinical plans, an avoidance plan is able to statistically significantly decrease the dose to key substructures. Meanwhile, the dose to OARs and the coverage of the target are comparable in the two plans. In addition, it can be observed that the avoidance plan statistically decreases the relative risks of CAD, CHF, and RP.

CONCLUSIONS

The substructure-avoidance planning strategy that incorporates the cardiac substructures into optimization process, can protect the important heart substructures, such as left ventricle, left anterior descending branch and pulmonary artery, achieving the substantive sparing of dose-sensitive cardiac structures, and have the potential to decrease the relative risks of CAD, CHF, and RP.

摘要

背景

心脏亚结构剂量比平均心脏剂量(MHD)更能预测主要不良心脏事件(MACE)。我们提出了一种重要心脏亚结构回避规划策略。

材料与方法

为 20 名患者生成了两个计划,即临床计划和心脏亚结构回避计划。选择了五个剂量敏感的亚结构,包括左心室、肺动脉、左前降支、左回旋支和冠状动脉。回避计划旨在满足目标标准和危及器官(OAR)限制的同时,最大限度地降低上述五个亚结构的剂量参数。剂量评估包括心脏亚结构的平均剂量和最大剂量以及几个体积参数。此外,我们还评估了冠心病(CAD)、慢性心力衰竭(CHF)和放射性肺炎(RP)的相对风险。

结果

Pearson 相关系数和线性回归拟合的 R 值表明,MHD 对心脏亚结构的平均剂量预测能力较差。与临床计划相比,回避计划能够显著降低关键亚结构的剂量。同时,两个计划中 OAR 剂量和靶区覆盖度相当。此外,可以观察到回避计划在统计学上降低了 CAD、CHF 和 RP 的相对风险。

结论

将心脏亚结构纳入优化过程的亚结构回避规划策略,可以保护左心室、左前降支和肺动脉等重要心脏亚结构,实现对剂量敏感的心脏结构的实质性保护,并有可能降低 CAD、CHF 和 RP 的相对风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4eb/10691619/b5035f555c3e/ACM2-24-e14119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4eb/10691619/14759efc37fb/ACM2-24-e14119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4eb/10691619/fbbec9f223d3/ACM2-24-e14119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4eb/10691619/b5035f555c3e/ACM2-24-e14119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4eb/10691619/14759efc37fb/ACM2-24-e14119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4eb/10691619/fbbec9f223d3/ACM2-24-e14119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4eb/10691619/b5035f555c3e/ACM2-24-e14119-g003.jpg

相似文献

1
A planning strategy may reduce the risk of heart diseases and radiation pneumonia: Avoiding the specific heart substructures.一种规划策略可能降低心脏病和放射性肺炎的风险:避免特定的心脏亚结构。
J Appl Clin Med Phys. 2023 Dec;24(12):e14119. doi: 10.1002/acm2.14119. Epub 2023 Aug 11.
2
Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).平均心脏剂量是否是乳腺癌放疗过程中左心室和冠状动脉暴露的相关替代参数:基于个体确定的辐射剂量的剂量学评估(BACCARAT 研究)。
Radiat Oncol. 2019 Feb 7;14(1):29. doi: 10.1186/s13014-019-1234-z.
3
Incorporating sensitive cardiac substructure sparing into radiation therapy planning.将敏感心脏亚结构保留纳入放射治疗计划。
J Appl Clin Med Phys. 2020 Nov;21(11):195-204. doi: 10.1002/acm2.13037. Epub 2020 Oct 18.
4
Cardiac substructure exposure in breast radiotherapy: a comparison between intensity modulated proton therapy and volumetric modulated arc therapy.心脏亚结构在乳腺癌放疗中的暴露:调强质子治疗与容积旋转调强弧形治疗的比较。
Acta Oncol. 2021 Aug;60(8):1038-1044. doi: 10.1080/0284186X.2021.1907860. Epub 2021 Mar 31.
5
Dosimetric Planning Comparison for Left-Sided Breast Cancer Radiotherapy: The Clinical Feasibility of Four-Dimensional-Computed Tomography-Based Treatment Planning Optimization.左侧乳腺癌放疗的剂量学计划比较:基于四维计算机断层扫描的治疗计划优化的临床可行性
Cureus. 2022 May 6;14(5):e24777. doi: 10.7759/cureus.24777. eCollection 2022 May.
6
Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT).容积调强弧形放疗(VMAT)下深吸气屏气(DIBH)对右乳腺癌局部区域照射益处的剂量学评估。
Acta Oncol. 2023 Feb;62(2):150-158. doi: 10.1080/0284186X.2023.2177976. Epub 2023 Feb 14.
7
Heart-sparing effect of postmastectomy radiotherapy for breast cancer patients: A dosimetric study of cardiac substructures.保乳术后放疗对乳腺癌患者的心脏保护作用:心脏亚结构的剂量学研究。
Med Dosim. 2020;45(3):246-251. doi: 10.1016/j.meddos.2020.01.004. Epub 2020 Feb 25.
8
Cardiac substructures exposure in left-sided breast cancer radiotherapy: Is the mean heart dose a reliable predictor of cardiac toxicity?左侧乳腺癌放疗中心脏亚结构的暴露:平均心脏剂量是否能可靠预测心脏毒性?
Cancer Radiother. 2021 May;25(3):229-236. doi: 10.1016/j.canrad.2020.09.003. Epub 2021 Jan 7.
9
Dosimetric Parameters After VMAT Adaptive Radiotherapy in Patients With Locally Advanced NSCLC Undergoing 4DCT.4DCT 引导下局部晚期 NSCLC 患者行 VMAT 自适应放疗后的剂量学参数。
Anticancer Res. 2023 Dec;43(12):5573-5582. doi: 10.21873/anticanres.16759.
10
A dosimetry study precisely outlining the heart substructure of left breast cancer patients using intensity-modulated radiation therapy.一项使用调强放射治疗精确勾勒左乳腺癌患者心脏亚结构的剂量学研究。
J Appl Clin Med Phys. 2014 Sep 8;15(5):4624. doi: 10.1120/jacmp.v15i5.4624.

引用本文的文献

1
Optimizing Dose Reduction to the Left Anterior Descending Artery in Patients With Locally Advanced Lung Cancer Treated With Definitive Radiation Therapy: A Feasibility Study of Coplanar Treatments Using Double-Stacked Multileaf Collimator.局部晚期肺癌患者行根治性放射治疗时优化左前降支动脉的剂量降低:使用双层多叶准直器的共面治疗可行性研究
Adv Radiat Oncol. 2025 Apr 2;10(6):101779. doi: 10.1016/j.adro.2025.101779. eCollection 2025 Jun.
2
Comparative Dosimetry and Biological Risk Assessment of Lung Oligometastasis SBRT: VMAT, Helical Tomotherapy, and CyberKnife.肺寡转移瘤立体定向体部放疗的剂量学比较及生物风险评估:容积调强弧形放疗、螺旋断层放疗和射波刀
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251330781. doi: 10.1177/15330338251330781. Epub 2025 Mar 28.
3

本文引用的文献

1
Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer.左前降支冠状动脉照射剂量与非小细胞肺癌患者主要不良心脏事件和死亡率的关系。
JAMA Oncol. 2021 Feb 1;7(2):206-219. doi: 10.1001/jamaoncol.2020.6332.
2
Incorporating sensitive cardiac substructure sparing into radiation therapy planning.将敏感心脏亚结构保留纳入放射治疗计划。
J Appl Clin Med Phys. 2020 Nov;21(11):195-204. doi: 10.1002/acm2.13037. Epub 2020 Oct 18.
3
Relationship between radiation doses to heart substructures and radiation pneumonitis in patients with thymic epithelial tumors.
Cardiac substructure delineation in radiation therapy - A state-of-the-art review.放射治疗中心脏亚结构的描绘——一项最新综述。
J Med Imaging Radiat Oncol. 2024 Dec;68(8):914-949. doi: 10.1111/1754-9485.13668. Epub 2024 May 17.
胸内上皮性肿瘤患者心脏亚结构受照剂量与放射性肺炎的关系。
Sci Rep. 2020 Jul 7;10(1):11191. doi: 10.1038/s41598-020-68168-y.
4
Novel Methodology to Investigate the Effect of Radiation Dose to Heart Substructures on Overall Survival.研究心脏亚结构辐射剂量对总生存期影响的新方法。
Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):1073-1081. doi: 10.1016/j.ijrobp.2020.06.031. Epub 2020 Jun 23.
5
Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy.同步双侧乳腺放疗中心脏及心脏亚结构的剂量 sparing:质子和光子放射治疗的剂量学研究
Front Oncol. 2020 Jan 10;9:1456. doi: 10.3389/fonc.2019.01456. eCollection 2019.
6
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.NRG肿瘤学RTOG 0617的长期结果:不可切除的III期非小细胞肺癌采用标准剂量与高剂量放化疗联合或不联合西妥昔单抗的疗效对比
J Clin Oncol. 2020 Mar 1;38(7):706-714. doi: 10.1200/JCO.19.01162. Epub 2019 Dec 16.
7
The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era.现代放疗时代纵隔淋巴瘤中Mean Heart Dose 的无谓意义。
Pract Radiat Oncol. 2020 May-Jun;10(3):e147-e154. doi: 10.1016/j.prro.2019.09.015. Epub 2019 Oct 2.
8
Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.肺癌患者的心脏辐射剂量、心脏疾病与死亡率。
J Am Coll Cardiol. 2019 Jun 18;73(23):2976-2987. doi: 10.1016/j.jacc.2019.03.500.
9
Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients.在容积调强弧形治疗技术的优化过程中纳入心脏亚结构可能会降低霍奇金淋巴瘤患者心脏病的风险。
Radiother Oncol. 2019 Sep;138:52-58. doi: 10.1016/j.radonc.2019.05.009. Epub 2019 May 27.
10
Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).平均心脏剂量是否是乳腺癌放疗过程中左心室和冠状动脉暴露的相关替代参数:基于个体确定的辐射剂量的剂量学评估(BACCARAT 研究)。
Radiat Oncol. 2019 Feb 7;14(1):29. doi: 10.1186/s13014-019-1234-z.